| 000 | 00713nam a22002177a 4500 | ||
|---|---|---|---|
| 008 | 200504b xxu||||| |||| 00| 0 eng d | ||
| 040 | _cVAD | ||
| 041 | _aEngels | ||
| 110 | _aSMMGP | ||
| 245 | _aClinical guidelines for the use of prolonged-release buprenorphine (Buvidal®) in the treatment of opioid dependence [PDF] | ||
| 260 |
_aShrewsbury _bSMMGP _c2020 |
||
| 300 | _a54 p. | ||
| 650 | _adrugs | ||
| 650 | _ainjecterende druggebruikers | ||
| 650 | _ahulpverlening | ||
| 650 | _abuprenorfine | ||
| 650 | _arichtlijnen | ||
| 650 | _abehandelrichtlijnen | ||
| 650 | _aVerenigd Koninkrijk | ||
| 856 | _uhttp://www.google.com/search?q=Clinical-guidelines-for-the-use-of-prolonged-release-buprenorphine | ||
| 999 |
_c21034 _d21034 |
||